GlassScriptPhysician profile
Brent Thomas Kempf
NPI 1659483246
$1,747.64
in general payments reported to CMS, 2019-2025
10 companies · $414 in 2025
The $414 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $158 · 2021: $91.70 · 2022: $462 · 2023: $385 · 2024: $237 · 2025: $414.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,025 · Education: $10.68.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,025.21 |
| Education | $10.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $385.25 | 2022-2023 | Krystexxa |
| Paratek Pharmaceuticals, INC. | $271.73 | 2020-2022 | |
| Abbott Laboratories | $254.88 | 2020-2024 | Proclaim |
| Kerecis Limited | $190.79 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Bioventus LLC | $125.00 | 2023 | Exogen Ultrasound Bone Healing System |
| Amgen INC. | $124.79 | 2025 | Krystexxa |
| Medartis INC. | $117.82 | 2020 | |
| Ani Pharmaceuticals, INC. | $98.06 | 2025 | Purified Cortrophin Gel |
| Medela LLC | $91.70 | 2021 | |
| Nevro Corp. | $87.62 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brent Kempf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.